BRIEF-IceCure Medical Says FDA Advisory Panel Meeting Date For Marketing Authorization Of ProSense Scheduled For Nov 7

Reuters
2024-09-12

Sept 12 (Reuters) - Icecure Medical Ltd :

* ICECURE MEDICAL LTD: FDA ADVISORY PANEL MEETING DATE FOR MARKETING AUTHORIZATION OF PROSENSE SCHEDULED FOR NOVEMBER 7

* ICECURE MEDICAL LTD - FDA DECISION REGARDING MARKETING AUTHORIZATION OF PROSENSE® EXPECTED BY EARLY 2025

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”